Top Articles on Health:   Arthritis: Osteoarthritis, Rheumatoid Arthritis, Gout ... More Anxiety: Panic Attack, Obsessive-Compulsive ... More Alzheimer's and Dementia: Alzheimer's disease, Vascular dementia, Frontotemporal ... More


ADD TO DEL.ICIO.US
ADD TO YAHOO MYWEB
ADD TO GOOGLE
ADD TO FURL
ADD TO REDDIT
ADD TO STUMBLEUPON
ADD TO MAGNOLIA
ADD TO NEWSVINE
 
Most Recent

health - Wanting a bite of everything: Hungry people crave more variety

health - Circumcision May Not Impact Sexual Sensation

health - Refusal of medical and surgical interventions common among chronically ill elderly

health - Alzheimer's drug based on Purdue-designed inhibitor begins clinical trials

health - The insect vector always bites twice

Popular Tags


More Articles

  Physicians Enlisted In Efforts To Keep Demented Drivers Off The Road
  Asthma: A short course of steroids reduces relapse
  How 'Mother Of Thousands' Makes Baby Plant
  Rheumatoid Arthritis Drug Linked To Serious Infections And Cancers
  Study demonstrated Rozerem (ramelteon) does not affect body sway



 
Researchers identify how to switch off cancer cell genes

researchers-identify-how-to-switch-off-cancer-cell-genes

"The study shows for the first time exactly how genes get shut down in cancer cells. It identifies what the target looks like so that new therapies can be designed to turn them back on."
 Mooshee.com - A new study led by researchers at the University of Southern California (USC) identifies how genes are silenced in cancer cells through distinct changes in the density of nucleosomes within the cells.

The findings, published in the Nov. 13 issue of the journal Cancer Cell, will enable researchers to explore new therapies to switch the genes back on and may lead to novel treatments for human cancers, says study lead author Peter A. Jones, Ph.D., D.Sc., director of the USC/Norris Comprehensive Cancer Center and Distinguished Professor at the Keck School of Medicine of USC.

"The study shows for the first time exactly how genes get shut down in cancer cells," Jones says. "It identifies what the target looks like so that new therapies can be designed to turn them back on."

The study showed that silencing of transcription start sites in some cancer cells involves distinct changes in nucleosomal occupancy'or the density of nucleosomes'in the cell. Researchers found that three nucleosomes, almost completely absent from the start site in normal cells, are present in the methylated and silenced promoter, suggesting that epigenetic silencing may be accomplished by the stable placement of nucleosomes into previously vacant positions.



DNA cytosine methylation'the addition of a group of specific chemicals to a stretch of DNA that can lock or silence a gene'may ultimately lead to silencing by enabling the stable presence of nucleosomes at the start sites of cancer-related genes, the study suggests.

"We believe these findings will contribute to the development of cancer therapies," Jones says. "We were surprised to find how rigid the inactive structure is, and how rapidly it can be dissolved by drug treatment."




--------------------------------
Article based on information provided by: University Of Southern California, Los Angeles, California U.S.A.
Adapted and published by: Mooshee.com
Originally released on: November 12



Next Article: Cell response to stress signals predicts tumors in women with common pre-breast cancer
More Articles On: Cancer, Genes, DNA, Lung Cancer, Lymphoma, Cancer Cells,

 

Google
 





home | rss feed | about | archive | podcasts | submit article | contact